| GLNAX | RSLDX | GLNAX / RSLDX | |
| Total Expense Ratio | 1.35 | 0.80 | 169% |
| Annual Report Gross Expense Ratio | 1.81 | 0.80 | 226% |
| Fund Existence | 14 years | 10 years | - |
| Gain YTD | 7.894 | 13.225 | 60% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 70.7M | 83.3B | 0% |
| Annual Yield % from dividends | 0.32 | 0.76 | 42% |
| Returns for 1 year | 2.01 | 6.84 | 29% |
| Returns for 3 years | 25.80 | 31.03 | 83% |
| Returns for 5 years | 1.66 | 3.56 | 47% |
| Returns for 10 years | 61.90 | 65.95 | 94% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GHYG | 45.96 | 0.13 | +0.28% |
| iShares US & Intl High Yield Corp Bd ETF | |||
| QMMY | 24.85 | 0.06 | +0.22% |
| FT Vest Nasdaq-100 Mod Buffr ETF - May | |||
| RSPE | 29.33 | N/A | +0.01% |
| Invesco ESG S&P 500 Equal Weight ETF | |||
| VOE | 175.69 | -0.59 | -0.33% |
| Vanguard Mid-Cap Value ETF | |||
| LABU | 147.82 | -5.53 | -3.61% |
| Direxion Daily S&P Biotech Bull 3X ETF | |||